Edited by

Robert C. Bast Jr., MD, Vice President for Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

John C. Byrd, MD, The Gordon and Helen Hughes Taylor Professor and Chair, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Carlo Croce, MD, Distinguished University Professor, The Ohio State University, The John W. Wolfe Chair in Human Cancer Genetics, Professor and Chair, Department of Cancer Biology and Genetics The Wexner Medical Center, The Ohio State University, Columbus, OH, USA

Ernest Hawk, MD, MPH, Vice President for Cancer Prevention & Head, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Fadlo R. Khuri, MD, President and Professor of Internal Medicine, Hematology and Medical Oncology, The American University of Beirut, Beirut, Lebanon

Raphael Pollock, MD, PhD, FACS, Director, The Ohio State University Comprehensive Cancer Center, Kathleen Wellenreiter Klotz Chair in Cancer Research, The Ohio State University Wexner Medical Center, Columbus, OH, USA

Apostolia M. Tsimberidou, MD, PhD, Professor, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Christopher Willett, MD, Professor and Chair, Department of Radiation Oncology, Duke University School of Medicine, Boston, Massachusetts, USA

Cheryl Willman, MD, Executive Director, Mayo Clinic Cancer Center Programs: Mayo Rochester/Midwest, Mayo Arizona, Mayo Florida, London, Abu Dhabi, Director, Mayo Clinic Comprehensive Cancer Center, Professor of Laboratory Medicine and Pathology, College of Medicine, Mayo Clinic Cancer Center, Rochester, NY, USA